ANI PHARMACEUTICALS INC (ANIP) Stock Analyst Earnings Estimates
NASDAQ:ANIP - Nasdaq - US00182C1036 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 216.1M 3.65% | 316.4M 46.41% | 486.816M 53.86% | 611.17M 25.54% | 739.2M 20.95% | 789.41M 6.79% | 818.32M 3.66% | 863.2M 5.48% | 891.7M 3.30% | 1.016B 13.94% | 1.056B 3.94% | 1.096B 3.79% | |
| EBITDA YoY % growth | 19.35M -52.03% | 30.15M 55.81% | 107.894M 257.86% | 153.25M 42.04% | 182.85M 19.31% | 209.51M 14.58% | 231.11M 10.31% | 247.05M 6.90% | 222.26M -10.03% | 250.92M 12.89% | N/A | N/A | |
| EBIT YoY % growth | -27.9M -548.84% | -29.5M -5.73% | 48.103M 263.06% | 152.86M 217.78% | 194.14M 27.01% | 220.86M 13.76% | 131.07M -40.65% | 160.85M 22.72% | 203.59M 26.57% | 214M 5.11% | N/A | N/A | |
| Operating Margin | -12.91% | -9.32% | 9.88% | 25.01% | 26.26% | 27.98% | 16.02% | 18.63% | 22.83% | 21.06% | N/A | N/A | |
| EPS YoY % growth | 3.26 -6.86% | 1.41 -56.75% | 4.72 234.75% | 5.11 8.19% | 5.67 11.02% | 6.73 18.70% | 7.31 8.56% | 8.24 12.77% | 8.60 4.43% | 9.89 15.00% | 10.16 2.68% | 10.46 2.91% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.46 46.37% | 1.12 -7.78% | 1.35 32.40% | 1.45 8.39% | 1.55 6.20% |
| Revenue Q2Q % growth | 178.87M 35.86% | 169.39M 23.26% | 181.04M 31.15% | 190.33M 28.31% | 196.52M 9.87% |
| EBITDA Q2Q % growth | 45.164M -32.10% | 38.387M 29.46% | 43.937M -11.27% | 48.069M 95.31% | 51.347M 13.69% |
| EBIT Q2Q % growth | 44.78M 565.77% | 40.806M 172.68% | 48.296M 139.87% | 52.488M 355.80% | 50.541M 12.87% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.34 5.51% | 1.11 | 0.23 | 20.97% |
| Q2 2024 Q2Q % growth | 1.02 -20.31% | 0.97 | 0.05 | 5.26% |
| Q1 2024 Q2Q % growth | 1.21 3.42% | 1.02 | 0.19 | 19.10% |
| Q4 2023 Q2Q % growth | 1.00 31.58% | 0.87 | 0.13 | 14.67% |
| Q3 2023 Q2Q % growth | 1.27 98.44% | 0.86 | 0.41 | 47.64% |
| Q2 2023 Q2Q % growth | 1.28 884.62% | 0.69 | 0.59 | 85.23% |
| Q1 2023 Q2Q % growth | 1.17 1,075.00% | 0.36 | 0.81 | 225.41% |
| Q4 2022 Q2Q % growth | 0.76 40.74% | 0.69 | 0.07 | 10.88% |
| Q3 2022 Q2Q % growth | 0.64 -36.63% | 0.56 | 0.08 | 13.57% |
| Q2 2022 Q2Q % growth | 0.13 -80.60% | 0.22 | -0.09 | -42.07% |
| Q1 2022 Q2Q % growth | -0.12 -111.54% | 0.10 | -0.22 | -226.05% |
| Q4 2021 Q2Q % growth | 0.54 -32.50% | 0.75 | -0.21 | -28.46% |
| Q3 2021 Q2Q % growth | 1.01 4.12% | 0.71 | 0.30 | 41.46% |
| Q2 2021 Q2Q % growth | 0.67 -2.90% | 0.70 | -0.03 | -4.11% |
| Q1 2021 Q2Q % growth | 1.04 | 0.72 | 0.32 | 43.61% |
| Q4 2020 Q2Q % growth | 0.80 -25.93% | 0.96 | -0.16 | -16.86% |
| Q3 2020 Q2Q % growth | 0.97 -21.14% | 0.90 | 0.07 | 7.66% |
| Q2 2020 Q2Q % growth | 0.69 -52.08% | 0.87 | -0.18 | -20.65% |
| Q1 2020 Q2Q % growth | 1.04 -20.00% | 0.91 | 0.13 | 14.56% |
| Q4 2019 Q2Q % growth | 1.08 | 1.21 | -0.13 | -10.50% |
| Q3 2019 Q2Q % growth | 1.23 | 1.46 | -0.23 | -15.63% |
| Q2 2019 Q2Q % growth | 1.44 | 1.31 | 0.13 | 9.86% |
| Q1 2019 Q2Q % growth | 1.30 | 1.07 | 0.23 | 21.77% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 148.332M 12.52% | 147.24M | 1.092M | 0.74% |
| Q2 2024 Q2Q % growth | 138.04M 18.44% | 131.63M | 6.41M | 4.87% |
| Q1 2024 Q2Q % growth | 137.43M 28.70% | 128.55M | 8.88M | 6.91% |
| Q4 2023 Q2Q % growth | 131.654M 39.76% | 124.65M | 7.004M | 5.62% |
| Q3 2023 Q2Q % growth | 131.829M 57.31% | 114.16M | 17.669M | 15.48% |
| Q2 2023 Q2Q % growth | 116.547M 57.71% | 100.67M | 15.877M | 15.77% |
| Q1 2023 Q2Q % growth | 106.786M 65.56% | 85.165M | 21.621M | 25.39% |
| Q4 2022 Q2Q % growth | 94.2M 54.68% | 87.862M | 6.338M | 7.21% |
| Q3 2022 Q2Q % growth | 83.8M 60.84% | 79.722M | 4.078M | 5.12% |
| Q2 2022 Q2Q % growth | 73.9M 52.06% | 73.542M | 358K | 0.49% |
| Q1 2022 Q2Q % growth | 64.5M 18.35% | 66.334M | -1.834M | -2.76% |
| Q4 2021 Q2Q % growth | 60.9M 6.28% | 57.426M | 3.474M | 6.05% |
| Q3 2021 Q2Q % growth | 52.1M -1.70% | 50.694M | 1.406M | 2.77% |
| Q2 2021 Q2Q % growth | 48.6M 0.21% | 49.011M | -411K | -0.84% |
| Q1 2021 Q2Q % growth | 54.5M 9.44% | 47.736M | 6.764M | 14.17% |
| Q4 2020 Q2Q % growth | 57.3M 19.38% | 55.352M | 1.948M | 3.52% |
| Q3 2020 Q2Q % growth | 53M 3.31% | 52.53M | 470K | 0.89% |
| Q2 2020 Q2Q % growth | 48.5M -10.85% | 47.872M | 628K | 1.31% |
| Q1 2020 Q2Q % growth | 49.8M -5.86% | 51.238M | -1.438M | -2.81% |
| Q4 2019 Q2Q % growth | 48M | 52.666M | -4.666M | -8.86% |
| Q3 2019 Q2Q % growth | 51.3M | 57.086M | -5.786M | -10.14% |
| Q2 2019 Q2Q % growth | 54.4M | 56.304M | -1.904M | -3.38% |
| Q1 2019 Q2Q % growth | 52.9M | 51.58M | 1.32M | 2.56% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -1.31% | 17.82% | -0.2% | 5.98% |
| Revenue | 0.14% | 24.87% | 0.05% | 1.5% |